Low to Intermediate Favorable Risk Prostate Cancer Management: Active Surveillance, Focal Therapy

ASU LIVE WEBINAR - SYMPOSIUM ON ORGAN CONFINED CARCINOMA PROSTATEПодробнее

Evolution of Active SurveillanceПодробнее

Active Surveillance: Intermediate Disease and High-Volume Grade Group 1 Prostate CancerПодробнее

Focal Therapy in Prostate CancerПодробнее

World Experts: Contemporary Conversations in Imaging and Focal Therapy for Prostate Cancer.Подробнее

Focal Therapy Society: Prostate Cancer Epidemiology and Active Surveillance. A Do Not Miss Session.Подробнее

Focal Therapy Overview - Ben SchurhamerПодробнее

Prostate Cancer: Understanding Causes, Diagnosis and TreatmentПодробнее

USI - ISU Smart Learning Program - Focal Therapy for Prostate Cancer -18th October 2024Подробнее

Surgery vs. Radiation Therapy for Localized Prostate Cancer: Expert Patient SeminarПодробнее

Bridging Innovation and Regulation: FDA Workshop at Focal Therapy Society Annual Meeting 2023Подробнее

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRIПодробнее

What’s new in advanced and metastatic prostate cancer treatment | BCH Lecture Sept 23Подробнее

The Impact of a Genomic Assay on Urologist Treatment Preference in Active Surveillance-Eligible MenПодробнее

Prostate Cancer Treatment Options | Online Health Talk 2023Подробнее

Am I a good candidate for focal treatment of prostate cancer ?Подробнее

Webinar: Is Focal Therapy Right for YOUR Prostate Cancer? 08/31/2023Подробнее

Jasmin Bektić - Is active surveillance for favorable intermediate risk prostate cancer safeПодробнее

UROwebinar: The role of focal therapy in prostate cancer for kidney transplant patientsПодробнее